Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-18

FDA Approved: YEZTUGO — Original Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved YEZTUGO (lenacapavir sodium) from Gilead as an original application for the treatment of HIV-1 infection in adults with multidrug-resistant virus o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • YEZTUGO (LENACAPAVIR SODIUM)

Snippet

ORIG AP for YEZTUGO (LENACAPAVIR SODIUM)